Provexis plc logo  
Provexis discovers, develops and licenses scientifically-
proven
technologies for the global functional food, medical food and
dietary supplement sectors.
 
 
 
     
  Announcements  
  Interim Results
2/12/08
Download full document (pdf)

Holding(s) in Company
3/10/08
Download full document (pdf)

Grant of share options
2/10/08
Download full document (pdf)

Result of AGM
2/10/08
Download full document (pdf)

Directorate change
1/10/08
Download full document (pdf)

Additional Listing
16/09/08
Download full document (pdf)

Annual Report and Accounts
11/09/08
Download full document (pdf)

Holding(s) in Company
02/09/08
Download full document (pdf)

Grant and surrender of share options
01/09/08
Download full document (pdf)

Directorate change
01/09/08
Download full document (pdf)

Holding(s) in Company
29/08/08
Download full document (pdf)

Result of meeting
26/08/08
Download full document (pdf)

Joint Venture project
21/08/08
Download full document (pdf)

Provexis plc Preliminary Results
01/08/08
Download full document (pdf)

Provexis plc Placing Announcement
01/08/08
Download full document (pdf)

Response to Share Price Movement
09/06/08
Download full document (pdf)

Notification of Major Interest in Shares
27/03/08
Download full document (pdf)

Notification of Major Interest in Shares
20/03/08
Download full document (pdf)

Notification of Major Interest in Shares
03/03/08
Download full document (pdf)

Notification of Major Interest in Shares
25/01/08
Download full document (pdf)

Notification of Major Interest in Shares
06/12/07
Download full document (pdf)

Grant of Options
29/11/07
Download full document (pdf)

Interim Results
19/11/07
Download full document (pdf)

Re Agreement
16/11/07
Download full document (pdf)

Collaboration Renewal
14/11/07
Download full document (pdf)

Additional Listing
01/10/07
Download full document (pdf)

Holding(s) in Company
14/09/07
Download full document (pdf)

Holding(s) in Company
14/09/07
Download full document (pdf)

AIM Rule 26 compliant website
17/08/07
Download full document (pdf)

Additional Listing
10/08/07
Download full document (pdf)

Change of Registered Office
03/08/07
Download full document (pdf)

Notification of Major Interest in Shares
25/07/07
Download full document (pdf)

AGM Statement
24/07/07
Download full document (pdf)

AGM Statement
24/07/07
Download full document (pdf)

Directorate Change
11/07/07
Download full document (pdf)

Annual Report and Accounts
03/07/07
Download full document (pdf)

Closure of Sirco juice brand
02/07/07
Download full document (pdf)

Notification of Major Interest in Shares
15/06/07
Download full document (pdf)

Director/PDMR Shareholding
06/06/07
Download full document (pdf)

Notification of Major Interest in Shares
04/06/07
Download full document (pdf)

Total Voting Rights
30/05/07
Download full document (pdf 26k)

Audited Results
30/05/07
Download full document (pdf 26k)

Additional Listing
10/05/07
Provexis announces that application has been made for the admission to AIM of 1,121,609 ordinary shares of 1p each in the Company ('Ordinary Shares'), pursuant to the exercise of options.
Download full document (pdf 28k)

Additional Listing
08/05/07
Provexis announces that application has been made for the admission to AIM of 3,365,871 ordinary shares of 1p each in the Company ('Ordinary Shares') pursuant to the exercise of options.
Download full document (pdf 28k)

Directorate Change
04/05/07
Provexis has appointed Jonathan Brett Diggines to its Board as a non-executive director with immediate effect
Download full document (pdf 37k)

Provexis plc Total Voting Rights
30/04/07
In conformity with the Transparency Directive's transitional provision 6 the Board of Provexis plc is required to notify the market of the following
Download full document (pdf 28k)

Holding in Company
17/04/07
Download full document (pdf 20k)

Notification of Major Interest in Shares
17/04/07
Download full document (pdf)

Notification of Major Interest in Shares
16/04/07
Download full document (pdf)

Notification of Major Interest in Shares
13/04/07
Download full document (pdf)

Result of Extraordinary General Meeting
10/04/07
Provexis plc announces that further to its announcement of 16 March 2007, all of the resolutions proposed at the Extraordinary General Meeting held earlier today were duly passed.
Download full document (pdf 25k)

Provexis and Unilever to co-develop Fruitflow(R) technology for application in food products that benefit healthy blood flow
30/03/07
Provexis has entered into a long-term collaboration agreement with Unilever plc to develop a new format of its patented Fruitflow(R) heart-health technology for application in Unilever's Food product portfolio.
Download full document (pdf 54k)

Grant of US Patent for Inflammatory Bowel Disease Technology
21/03/07
Provexis plc announces that the US Patent Office has granted a patent for its plantain-based extract for the treatment of Inflammatory Bowel Disease ("IBD").
Download full document (pdf 30k)

Placing of New Ordinary Shares and Notice of Extraordinary General Meeting
16/03/07
Provexis plc announces it proposes to raise approximately £2.15m (before expenses) by way of a conditional placing at a price of 1.5p, to provide working capital for the development of its patented Fruitflow(R) heart-health technology, as well as advancing its plantain-based technology for the treatment of Crohn's Disease.
Download full document (pdf 63k)

Fruitflow Clears FDA GRAS Review Process
28/02/07
Provexis is delighted to announce that the US Food and Drug Administration ("FDA") has no objection to the conclusion that the Fruitflow heart-health technology is Generally Recognized As Safe ("GRAS"), clearing the way for its use in the USA.
Download full document (pdf 39k)

Total Voting Rights
21/12/06
Download full document (pdf 13k)

Interim Results for the six months ended 30 September 2006
19/12/06
Provexis plc, the nutraceutical company that develops scientifically-proven functional and medical foods, announces its unaudited interim results for the six months ended 30 September 2006.
Download full document (pdf 113k)

Sirco Distribution Gains
03/11/06
Provexis, the nutraceutical company that develops scientifically-proven functional and medical foods, announces that it has extended the distribution of its Sirco(r) heart health juice drink, securing 283 Asda outlets from 13 November. This is in addition to the recent extension of the product’s high street presence via 110 outlets of the independent specialist food retailer Julian Graves.
Download full document (pdf 14k)

Fruitflow Licence Delay
01/11/06
Provexis, the nutraceutical company that develops scientifically-proven functional and medical foods, announces that discussions for the licensing of its Fruitflow® bioactive food ingredient to a major international brand owner will now extend into 2007, due to the extension of the technical development timeline.
Download full document (pdf 27k)

Result of Annual General Meeting
29/09/06
The Annual General Meeting of the Company was held today and all resolutions were passed.
Download full document (pdf 11k)

Annual General Meeting Statement
29/09/06
At Provexis plc’s Annual General Meeting to be held this morning, the non-executive Chairman of Provexis plc, Dawson Buck, will give the following statement and update on current trading.
Download full document (pdf 24k)

Additional Listing
10/08/06
Download full document (pdf 12k)

Annual Report and Accounts
11/09/06
Download full document (pdf 14k)

Morrisons Distribution Agreement
31/07/06
Provexis, the nutraceutical company that develops scientifically-proven functional and medical foods, announces that it has extended the distribution of its Sirco™ heart health juice drink, securing 235 Morrisons outlets with effect from 14 August 2006.
Download full document (pdf 26k)

Directorate Change
24/07/06
Provexis plc, the nutraceutical company that develops scientifically-proven functional and medical foods, today announces that Dr Stephen Franklin is stepping down with immediate effect from his role as Chief Executive Officer, and will not be seeking re-election to the Board at the Company’s forthcoming Annual General Meeting. Dr Franklin will continue to work with the Company until early 2007 as Acting Director of Research. In this capacity he will complement the Company’s research and development team progressing late phase development of the Company’s proprietary technologies. The Company announces that Stephen Moon has been appointed as Chief Executive Officer with immediate effect. Stephen Moon, formerly Commercial Director of Provexis, has been with the Company since February 2003.
Download full document (pdf 29k)

Exclusivity Agreement
24/07/06
Provexis, the nutraceutical company that develops scientifically-proven functional and medical foods, announces that it has entered into an exclusivity agreement for a period of 12 months with a major global branded food business (“Partner”), who, for reasons of confidentiality, cannot be named, for the joint development and use of its patented Fruitflow™ heart-health technology. Fruitflow™ is a bioactive food ingredient that reduces blood platelet aggregation, a significant contributing factor to thrombosis, which can cause heart attack or stroke.
Download full document (pdf 29k)

Preliminary Results For The Year Ended 31 March 2006
15/06/06
Provexis plc the nutraceutical company that develops scientifically-proven functional and medical foods, announces its unaudited preliminary results for the year ended 31 March 2006.
Download full document (pdf 103k)

Standby Equity Distribution Agreement for up to £3m
06/06/06
Provexis, the nutraceutical company that develops scientifically-proven functional and medical foods, announces that on 5 June 2006, it entered into a Standby Equity Distribution Agreement ("SEDA") with Cornell Capital Partners, LP ("Cornell").
Download full document (pdf 17k)

Sirco™ science to be published in leading scientific journal
16/05/06
Provexis, the nutraceutical company that develops scientifically-proven functional and medical foods, announces a major international scientific endorsement for its lead product Sirco™. Two scientific papers, which detail the clinical efficacy of Sirco™, are to be published by the American Journal of Clinical Nutrition (AJCN). The AJCN is internationally recognised as the highest-ranked peer-reviewed journal in the nutrition field.
Download full document (pdf)

Change to current Sirco Listings
20/04/06
Provexis, the nutraceutical company that develops scientifically-proven functional and medical foods, announces that J Sainsbury will de-list Sirco™ from 17 May 2006.
Download full document (pdf 27k)

Trading Update
06/04/06
Provexis, the nutraceutical company that develops scientifically-proven functional and medical foods, issues a trading update for the year ended 31 March 2006.
Download full document (pdf 26k)

Fruitflow™ has GRAS status affirmed in the United States
09/03/06
Provexis, the nutraceutical company that develops scientifically-proven functional and medical foods, announces that an independent Expert Panel in the United States has affirmed Fruitflow™ to be Generally Recognised as Safe (“GRAS”), paving the way for products containing Fruitflow™ to be marketed in the United States and Canada.
Download full document (pdf 40k)

Significant Increase in Number of Distribution Outlets for Sirco™
23/01/06
Provexis, the nutraceutical company that develops scientifically-proven functional and medical foods, announces a significant increase in the number of distribution outlets for its Sirco™ heart health juice drink, under the terms of its most recent distribution agreement with a market leading supermarket chain.
Download full document (pdf 29k)

Further Major Distribution Agreement for Sirco™
09/01/06
Provexis, the nutraceutical company that develops scientifically-proven functional and medical foods, announces a further distribution agreement with a market leading supermarket chain for its Sirco™ heart health juice drink.
Download full document (pdf 29k)

UK Launch of Sirco
16/12/05
Provexis, the nutraceutical company that develops scientifically-proven functional and medical foods, is delighted to confirm the launch of it Sirco heart health juice drink in the UK in January 2006.
Download full document (pdf 11k)

Appointment of Finance Director Designate and Company Secretary Designate
09/12/05
Provexis, the nutraceutical company that develops scientifically-proven functional and medical foods, announces the appointment of Stewart William Slade, 56, as Finance Director designate and Company Secretary designate, with immediate effect.
Download full document (pdf 55k)

Interim Results for the half year ended 30 September 2005
23/11/05
Provexis plc, the nutraceutical company that develops scientifically-proven functional and medical foods, today announces its interim results for the six months ended 30 September 2005.
Download full document (pdf 268k)

Provexis plc is awarded Research Grant for Crohn's Disease Technology from North West Development Agency
07/11/05
Provexis is delighted to announce that it has been awarded a research grant for its Crohn's disease technology from the North West Development Agency.
Download full document (pdf 42k)

US patent awarded covering Fruitflow technology
03/11/05
Provexis plc announces that it has received a patent grant from the United States Patent Office covering its Fruitflow™ technology.
Download full document (pdf 36k)

Disposal of Altú
05/10/05
Provexis plc announces the sale of its Altú food business to Go Lower Limited for a cash consideration of £75,000 which will be used for working capital purposes.
Download full document (pdf 16k)

Collaboration agreement for Crohn's disease Technology
12/09/05
Provexis, the nutraceutical company that develops scientifically proven functional and medical foods, is delighted to announce that it has entered into a collaboration agreement with a leading clinical nutrition company.
Download full document (pdf 38k)

Provexis AGM Statement
23/08/05
Dawson Buck, Chairman of Provexis plc, will make the following statement at today's Annual General Meeting:
"Provexis plc was admitted to trading on AIM exactly two months ago. This was the coming together of two businesses, Provexis Limited and Nutrinnovator Holdings plc...
Download full document (pdf 48k)

Provexis and H-E-A-R-T UK enter product endorsement agreement
01/08/05
Provexis, the nutraceutical company that develops scientifically proven functional and medical foods, is delighted to announce their entry into an initial three year agreement with the registered heart health charity, H-E-A-R-T UK.
Download full document (pdf 66k)

Preliminary Results For The Year Ended 31 March 2005
22/07/05
Provexis plc, the leading nutraceutical business and developer and marketer of superior functional foods, announces its preliminary results for the year ended 31 March 2005
Download full document (pdf 1)

Provexis plc Commencement of Trading
24/06/05
Further to the announcement by Nutrinnovator Holdings plc on 23rd June 2005, Provexis plc ("Provexis" or the "Company")…
Download full document (pdf 52k)

Nutrinnovator Holdings plc - Capital Re-organisation, Placing and Admission to Trading
23/06/05
Further to its announcement of 20 June 2005, the Company announces the successful completion of…
Download full document (pdf 38k)

Nutrinnovator Holdings plc - Result of Extraordinary General Meeting
20/06/05
At its Extraordinary General Meeting today, the Company received approval from its shareholders…
Download full document (pdf 51k)

Proposed acquisition of Provexis Limited
26/05/05
Nutrinnovator today announces it has reached agreement with Provexis’ shareholders to acquire…
Download full document (pdf 137k)
 
     
 
   
  Bullet Image Share price information
Trade time Loading...  
Latest price Loading...
Price change Loading...
Hemscott Ltd - Disclaimer